Zai Lab (ZLAB) Research & Development (2018 - 2026)
Zai Lab recorded quarterly Research & Development of $65.6 million in Q1 2026, up 6.42% quarter-over-quarter from $61.6 million in Q4 2025, and up 8.01% year-over-year from $60.7 million in Q1 2025.
Zai Lab's Research & Development history runs 9 years deep, the most recent figure standing at $65.6 million for Q1 2026.
- In Q1 2026, Research & Development rose 8.01% year-over-year to $65.6 million; the TTM figure through Mar 2026 stood at $225.8 million (down 6.16% YoY), while the FY2025 annual figure was $220.9 million, down 5.8% from the prior year.
- Research & Development came in at $65.6 million for Q1 2026 at Zai Lab, up from $61.6 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $99.5 million in Q3 2022 to a low of $47.9 million in Q3 2025.
- A 5-year average of $63.1 million and a median of $61.6 million in 2024 frame the typical range for Research & Development.
- On a YoY basis, Research & Development climbed as much as 80.48% in 2022 and fell as far as 73.58% in 2022.
- Zai Lab's Research & Development stood at $66.9 million in 2022, then rose by 22.41% to $81.9 million in 2023, then plunged by 36.24% to $52.3 million in 2024, then rose by 17.95% to $61.6 million in 2025, then gained by 6.42% to $65.6 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $65.6 million, $61.6 million, and $47.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Zai Lab | 19.59 Bn | 19.49 Bn | 61.30 Mn | 65.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.59 Mn |
| Dec 31, 2025 | 61.63 Mn |
| Sep 30, 2025 | 47.93 Mn |
| Jun 30, 2025 | 50.61 Mn |
| Mar 31, 2025 | 60.73 Mn |
| Dec 31, 2024 | 52.25 Mn |
| Sep 30, 2024 | 65.98 Mn |
| Jun 30, 2024 | 61.63 Mn |
| Mar 31, 2024 | 54.65 Mn |
| Dec 31, 2023 | 81.95 Mn |
| Sep 30, 2023 | 58.77 Mn |
| Jun 30, 2023 | 76.68 Mn |
| Mar 31, 2023 | 48.47 Mn |
| Dec 31, 2022 | 66.95 Mn |
| Sep 30, 2022 | 99.52 Mn |
| Jun 30, 2022 | 66.08 Mn |
| Mar 31, 2022 | 53.85 Mn |
| Dec 31, 2021 | 172.09 Mn |
| Sep 30, 2021 | 55.14 Mn |
| Jun 30, 2021 | 142.22 Mn |
| Mar 31, 2021 | 203.85 Mn |
| Dec 31, 2020 | 62.56 Mn |
| Sep 30, 2020 | 58.10 Mn |
| Jun 30, 2020 | 68.31 Mn |
| Mar 31, 2020 | 33.74 Mn |
| Dec 31, 2019 | 252.35 Mn |
| Sep 30, 2019 | -51.20 Mn |
| Dec 31, 2018 | 184.90 Mn |